|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2007-4-6
|
|
pubmed:abstractText |
Adjuvant chemotherapy in premenopausal women with breast cancer may induce amenorrhea, which can affect fertility, choice of hormonal therapy, and increase the risk of late toxicity. The incidence of chemotherapy-induced amenorrhea (CIA) resulting from doxorubicin and cyclophosphamide (AC) followed by a taxane (T) is poorly characterized.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
1537-453X
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
30
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
126-32
|
|
pubmed:meshHeading |
pubmed-meshheading:17414460-Adult,
pubmed-meshheading:17414460-Amenorrhea,
pubmed-meshheading:17414460-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:17414460-Breast Neoplasms,
pubmed-meshheading:17414460-Cyclophosphamide,
pubmed-meshheading:17414460-Doxorubicin,
pubmed-meshheading:17414460-Drug Administration Schedule,
pubmed-meshheading:17414460-Female,
pubmed-meshheading:17414460-Humans,
pubmed-meshheading:17414460-Middle Aged,
pubmed-meshheading:17414460-Parity,
pubmed-meshheading:17414460-Pregnancy,
pubmed-meshheading:17414460-Premenopause,
pubmed-meshheading:17414460-Questionnaires,
pubmed-meshheading:17414460-Retrospective Studies,
pubmed-meshheading:17414460-Socioeconomic Factors,
pubmed-meshheading:17414460-Taxoids
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
The rates of chemotherapy-induced amenorrhea in patients treated with adjuvant doxorubicin and cyclophosphamide followed by a taxane.
|
|
pubmed:affiliation |
Breast Care Center, The Methodist Hospital and Baylor College of Medicine, Houston, Texas, USA. yltham@breastcenter.tmc.edu
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
